Loading clinical trials...
Loading clinical trials...
The investigators propose to develop and validate MyRareDiet® (MRD) to address an unmet need in the inborn errors of metabolism (IEM) population to assist with dietary management designed to increase ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Oregon Health and Science University
Collaborators
NCT06805695 · Ornithine Transcarbamylase Deficiency, Ornithine Transcarbamylase Deficiency Disease, and more
NCT04602325 · Urea Cycle Disorder, Organic Acidemia, and more
NCT06953505 · Urea Cycle Disorders, Organic Acidemias, and more
NCT05051657 · Phenylketonurias, PKU, and more
NCT01257737 · Urea Cycle Disorders
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions